NEXTGEN HEALTHCARE INC (NXGN) Stock Analyst Ratings
NASDAQ:NXGN - Nasdaq - US65343C1027 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 51% to NXGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.41. This target is 1.97% above the current price.
NXGN was analyzed by 13 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about NXGN.
In the previous month the buy percentage consensus was at a similar level.
NXGN was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-08 | Truist Securities | Maintains | Hold -> Hold |
| 2023-09-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-08-28 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-07-25 | Guggenheim | Reiterate | Buy -> Buy |
| 2023-07-25 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2023-07-25 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-06-12 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-05-23 | Guggenheim | Maintains | Buy -> Buy |
| 2023-05-22 | Truist Securities | Maintains | Hold -> Hold |
| 2023-05-18 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-05-17 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-04-12 | Stephens & Co. | Initiate | Overweight |
| 2022-10-26 | SVB Leerink | Maintains | Outperform |
| 2022-09-07 | Truist Securities | Initiate | Hold |
| 2022-05-06 | Guggenheim | Upgrade | Neutral -> Buy |
| 2022-05-04 | SVB Leerink | Maintains | Outperform |
| 2022-04-14 | Guggenheim | Initiate | Neutral |
| 2022-01-06 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-07-30 | RBC Capital | Maintains | Sector Perform |